Literature DB >> 33628839

Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.

Yan Li1, Lei Wang2, Bojun Xu1, Liangbin Zhao1, Li Li1, Keyang Xu3, Anqi Tang1, Shasha Zhou1, Lu Song1, Xiao Zhang1, Huakui Zhan1.   

Abstract

BACKGROUND: Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus and is a major cause of end-stage kidney disease. Cordyceps sinensis (Cordyceps, Dong Chong Xia Cao) is a widely applied ingredient for treating patients with DN in China, while the molecular mechanisms remain unclear. This study is aimed at revealing the therapeutic mechanisms of Cordyceps in DN by undertaking a network pharmacology analysis.
MATERIALS AND METHODS: In this study, active ingredients and associated target proteins of Cordyceps sinensis were obtained via Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and Swiss Target Prediction platform, then reconfirmed by using PubChem databases. The collection of DN-related target genes was based on DisGeNET and GeneCards databases. A DN-Cordyceps common target interaction network was carried out via the STRING database, and the results were integrated and visualized by utilizing Cytoscape software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to determine the molecular mechanisms and therapeutic effects of Cordyceps on the treatment of DN.
RESULTS: Seven active ingredients were screened from Cordyceps, 293 putative target genes were identified, and 85 overlapping targets matched with DN were considered potential therapeutic targets, such as TNF, MAPK1, EGFR, ACE, and CASP3. The results of GO and KEGG analyses revealed that hub targets mainly participated in the AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, PI3K-Akt signaling pathway, and IL-17 signaling pathway. These targets were correlated with inflammatory response, apoptosis, oxidative stress, insulin resistance, and other biological processes.
CONCLUSIONS: Our study showed that Cordyceps is characterized as multicomponent, multitarget, and multichannel. Cordyceps may play a crucial role in the treatment of DN by targeting TNF, MAPK1, EGFR, ACE, and CASP3 signaling and involved in the inflammatory response, apoptosis, oxidative stress, and insulin resistance.
Copyright © 2021 Yan Li et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33628839      PMCID: PMC7884116          DOI: 10.1155/2021/8891093

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  56 in total

1.  Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.

Authors:  Zhilian Li; Yan Li; Jessica M Overstreet; Sungjin Chung; Aolei Niu; Xiaofeng Fan; Suwan Wang; Yinqiu Wang; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2018-06-29       Impact factor: 9.461

2.  Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid.

Authors:  Naveen K V Gundala; Vegi G M Naidu; Undurti N Das
Journal:  Biochem Biophys Res Commun       Date:  2018-01-06       Impact factor: 3.575

3.  Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.

Authors:  Juan F Navarro; Carmen Mora; Mercedes Muros; Javier García
Journal:  Nephrol Dial Transplant       Date:  2006-08-25       Impact factor: 5.992

4.  Association between the PPARG gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.

Authors:  RuiChao Yu; Hong Bo; SongMing Huang
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-21

Review 5.  Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules.

Authors:  Undurti N Das
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-01-05       Impact factor: 4.006

6.  Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.

Authors:  Emma Börgeson; Andrew M F Johnson; Yun Sok Lee; Andreas Till; Gulam Hussain Syed; Syed Tasadaque Ali-Shah; Patrick J Guiry; Jesmond Dalli; Romain A Colas; Charles N Serhan; Kumar Sharma; Catherine Godson
Journal:  Cell Metab       Date:  2015-06-04       Impact factor: 27.287

7.  Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products.

Authors:  Dazhong Xu; John M Kyriakis
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

8.  Cordyceps sinensis prevents contrast-induced nephropathy in diabetic rats: its underlying mechanism.

Authors:  Kai Zhao; Qiaoying Gao; Chunhui Zong; Lixiu Ge; Jinjin Liu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 9.  Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.

Authors:  Guang-dong Sun; Chao-yuan Li; Wen-peng Cui; Qiao-yan Guo; Chang-qing Dong; Hong-bin Zou; Shu-jun Liu; Wen-peng Dong; Li-ning Miao
Journal:  J Diabetes Res       Date:  2015-11-15       Impact factor: 4.011

10.  Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.

Authors:  Abigail C Lay; Jenny A Hurcombe; Virginie M S Betin; Fern Barrington; Ruth Rollason; Lan Ni; Lawrence Gillam; Grace M E Pearson; Mette V Østergaard; Hellyeh Hamidi; Rachel Lennon; Gavin I Welsh; Richard J M Coward
Journal:  Diabetologia       Date:  2017-08-29       Impact factor: 10.122

View more
  6 in total

Review 1.  Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review.

Authors:  Wu Liu; Yiwei Gao; Yi Zhou; Fangning Yu; Xinyi Li; Ning Zhang
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

2.  A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis.

Authors:  Rini Varghese; Anuradha Majumdar
Journal:  Curr Res Physiol       Date:  2022-01-01

3.  Effects and Components of Herb Pair Huanglian-Banxia on Diabetic Gastroparesis by Network Pharmacology.

Authors:  Guoqiang Liang; Lurong Zhang; Guorong Jiang; Xuanyi Chen; Yang Zong; Fei Wang
Journal:  Biomed Res Int       Date:  2021-10-18       Impact factor: 3.411

Review 4.  Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.

Authors:  Tianwen Yao; Wenxiang Su; Shisheng Han; Yan Lu; Yanqiu Xu; Min Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 5.  Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products.

Authors:  Wei Tan; Yunyan Wang; Hongmei Dai; Junhui Deng; Zhifen Wu; Lirong Lin; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

6.  Network Pharmacology and Molecular Docking Analysis Explores the Mechanisms of Cordyceps sinensis in the Treatment of Oral Lichen Planus.

Authors:  Hexin Ma; Guofang Wang; Xiaomeng Guo; Yao Yao; Chunshen Li; Xibo Li; Mingzhe Xin; Xiaohui Xu; Shilong Zhang; Zhi Sun; Hongyu Zhao
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.